Literature DB >> 5133515

Leukotactic factors in health and disease.

P A Ward.   

Abstract

Selected studies of neutrophil chemotaxis have been reviewed. While the multiplicity of chemotactic factors for neutrophils is recognized, it is especially evident that many of these factors are derivatives of the complement system. Also striking is the diversity of enzymes capable of producing chemotactically active fragments from complement proteins. Four conditions are cited in which complement-derived chemotactic factors are found in body fluids or tissue extracts: rheumatoid arthritis, inflammatory nonrheumatoid arthritis, immunologic vasculitis and myocardial infarcts. The interactions of chemotactic factors with neutrophils have been described in terms of the three neutrophil-associated esterases required for chemotactic responsiveness of these cells. Finally, several drugs have been studied, some of which are chemosuppressive in the chemotaxis system. These findings provide some suggestions about the mechanisms of leukocyte chemotaxis and may be relevant to the anti-inflammatory activity of these drugs.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5133515      PMCID: PMC2047615     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Potassium reversible inhibition of leukotaxis by ouabain.

Authors:  P A Ward; E L Becker
Journal:  Life Sci       Date:  1970-03-22       Impact factor: 5.037

2.  A neutrophil chemotactic factor from human C'5.

Authors:  P A Ward; L J Newman
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

3.  C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.

Authors:  P A Ward; J H Hill
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

4.  Reversal of chemotaxis in vitro and chemotactic activity of leukocyte fractions.

Authors:  H P Cornely
Journal:  Proc Soc Exp Biol Med       Date:  1966-07

5.  Complement-derived leukotactic factors in inflammatory synovial fluids of humans.

Authors:  P A Ward; N J Zvaifler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

6.  C3 leukotactic factors produced by a tissue protease.

Authors:  J H Hill; P A Ward
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

7.  The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.

Authors:  J H Hill; P A Ward
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

8.  The chemosuppression of chemotaxis.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

9.  Esterases of the polymorphonuclear leukocyte capable of hydrolyzing acetyl DL-phenyl-alanine beta-naphthyl ester. Relationship to the activatable esterase of chemotaxis.

Authors:  E L Becker; P A Ward
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  24 in total

1.  Comparison of leukocyte count and function in smoking and nonsmoking young men.

Authors:  R C Noble; B B Penny
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

2.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

3.  The effect of bovine serum albumin on the in vitro inhibition of chemotaxis by anti-inflammatory agents.

Authors:  I Rivkin
Journal:  Agents Actions       Date:  1977-10

4.  Polymorphonuclear neutrophils function in splenectomized patients.

Authors:  H Wysocki; B Wierusz-Wysocka; H Karoń; J Dotka; A Wykretowicz; A Szczepanik; R Klimas
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  Studies on cell motility in inflammation. II. The in vivo effect of anti-inflammatory and anti-rheumatic drugs on chemotaxis in vitro.

Authors:  L Parente; M S Koh; D A Willoughby; A Kitchen
Journal:  Agents Actions       Date:  1979-06

Review 6.  Leukotaxis and leukotactic disorders. A review.

Authors:  P A Ward
Journal:  Am J Pathol       Date:  1974-12       Impact factor: 4.307

Review 7.  Steroids, aspirin, and inflammation.

Authors:  E Katler; G Weissmann
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

8.  The effects on polymorphonuclear leucocyte function of prednisolone and azathioprine in vivo and prednisolone, azathioprine and 6-mercaptopurine in vitro.

Authors:  A Losito; D G Williams; G Cooke; L Harris
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

9.  Asbestos-induced lung inflammation. Role of local macrophage-derived chemotactic factors in accumulation of neutrophils in the lungs.

Authors:  M Rola-Pleszczynski; S Gouin; R Bégin
Journal:  Inflammation       Date:  1984-03       Impact factor: 4.092

10.  Studies of glycogen-induced inflammation of mice. Dynamics of inflammatory responses and influence of antiinflammatory drugs and protease inhibitors.

Authors:  T Yamashita; Y Ishibashi; I Nagaoka; K Kasuya; K Masuda; H Warabi; Y Shiokawa
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.